Eli Lilly's $1B buyout bet for Protomer brings the 'next frontier' in smart...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 14, 2021 at 10:22: AM
via Eli Lilly is looking to shore up its future diabetes franchise by putting $1 billion on the table to buy out next-gen biotech Protomer.

article source
 

<



Similar threads

cafead
FDA approves Eli Lilly&#039;s drug for eczema
Replies
0
Views
7
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Eli Lilly&#039;s weight loss drug tirzepatide gets approval in China
Replies
0
Views
27
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Eli Lilly&#039;s Alzheimer&#039;s Drug Obtains FDA Approval. Here&#039;s Why the Stock Isn&#039;t Taking Off.
Replies
0
Views
34
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Eli Lilly Alzheimer&#039;s drug approved by US FDA
Replies
0
Views
38
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Biden joins Sanders&#039; campaign targeting Novo Nordisk, Eli Lilly&#039;s diabetes and obesity drug prices
Replies
0
Views
41
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote